PRKCB and cancer: In the current study we analyzed for the first time the effects of PKCβ inhibition using Enzastaurin in combination with Plk1 inhibition using SBE13 on cell cycle regulation and induction of apoptosis in different cancer cell lines and in immortalized, but not transformed hTERT-RPE1 cells.